- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
The Vendor Neutral Archive (VNA) and PACS market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Vendor Neutral Archive (VNA) and PACS market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Enterprise accounting for % of the Vendor Neutral Archive (VNA) and PACS global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While by Delivery Mode segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Vendor Neutral Archive (VNA) and PACS include Agfa Healthcare NV, Dell Technologies, Fujifilm Holdings Corporation, GE Healthcare, and IBM Corporation, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Vendor Neutral Archive (VNA) and PACS market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
by Delivery Mode
Cloud-hosted
On-Site (Premise)
Hybrid
by Imaging Modality
Angiography
Mammography
Computed Tomography
Digital Fluoroscopy
Digital Radiography
Magnetic Resonance Imaging
Nuclear Imaging
Ultrasound
Other
by Usage Model
Single Department
Multiple Departments
Multiple Sites
Market segment by Application, can be divided into
Enterprise
Cardiology
Radiology
Market segment by players, this report covers
Agfa Healthcare NV
Dell Technologies
Fujifilm Holdings Corporation
GE Healthcare
IBM Corporation
Koninklijke Philips NV
Lexmark International
McKesson Corporation
Novarad Corporation
Siemens
TeraMedica
Merge Health
BridgeHead
Carestream Health
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Vendor Neutral Archive (VNA) and PACS product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Vendor Neutral Archive (VNA) and PACS, with revenue, gross margin and global market share of Vendor Neutral Archive (VNA) and PACS from 2019 to 2022.
Chapter 3, the Vendor Neutral Archive (VNA) and PACS competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Vendor Neutral Archive (VNA) and PACS market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Vendor Neutral Archive (VNA) and PACS research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Vendor Neutral Archive (VNA) and PACS
1.2 Classification of Vendor Neutral Archive (VNA) and PACS by Type
1.2.1 Overview: Global Vendor Neutral Archive (VNA) and PACS Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Vendor Neutral Archive (VNA) and PACS Revenue Market Share by Type in 2021
1.2.3 Cloud-hosted
1.2.4 On-Site (Premise)
1.2.5 Hybrid
1.3 Global Vendor Neutral Archive (VNA) and PACS Market by Application
1.3.1 Overview: Global Vendor Neutral Archive (VNA) and PACS Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Enterprise
1.3.3 Cardiology
1.3.4 Radiology
1.4 Global Vendor Neutral Archive (VNA) and PACS Market Size & Forecast
1.5 Global Vendor Neutral Archive (VNA) and PACS Market Size and Forecast by Region
1.5.1 Global Vendor Neutral Archive (VNA) and PACS Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Vendor Neutral Archive (VNA) and PACS Market Size by Region, (2017-2022)
1.5.3 North America Vendor Neutral Archive (VNA) and PACS Market Size and Prospect (2017-2028)
1.5.4 Europe Vendor Neutral Archive (VNA) and PACS Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Vendor Neutral Archive (VNA) and PACS Market Size and Prospect (2017-2028)
1.5.6 South America Vendor Neutral Archive (VNA) and PACS Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Vendor Neutral Archive (VNA) and PACS Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Vendor Neutral Archive (VNA) and PACS Market Drivers
1.6.2 Vendor Neutral Archive (VNA) and PACS Market Restraints
1.6.3 Vendor Neutral Archive (VNA) and PACS Trends Analysis
2 Company Profiles
2.1 Agfa Healthcare NV
2.1.1 Agfa Healthcare NV Details
2.1.2 Agfa Healthcare NV Major Business
2.1.3 Agfa Healthcare NV Vendor Neutral Archive (VNA) and PACS Product and Solutions
2.1.4 Agfa Healthcare NV Vendor Neutral Archive (VNA) and PACS Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Agfa Healthcare NV Recent Developments and Future Plans
2.2 Dell Technologies
2.2.1 Dell Technologies Details
2.2.2 Dell Technologies Major Business
2.2.3 Dell Technologies Vendor Neutral Archive (VNA) and PACS Product and Solutions
2.2.4 Dell Technologies Vendor Neutral Archive (VNA) and PACS Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Dell Technologies Recent Developments and Future Plans
2.3 Fujifilm Holdings Corporation
2.3.1 Fujifilm Holdings Corporation Details
2.3.2 Fujifilm Holdings Corporation Major Business
2.3.3 Fujifilm Holdings Corporation Vendor Neutral Archive (VNA) and PACS Product and Solutions
2.3.4 Fujifilm Holdings Corporation Vendor Neutral Archive (VNA) and PACS Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Fujifilm Holdings Corporation Recent Developments and Future Plans
2.4 GE Healthcare
2.4.1 GE Healthcare Details
2.4.2 GE Healthcare Major Business
2.4.3 GE Healthcare Vendor Neutral Archive (VNA) and PACS Product and Solutions
2.4.4 GE Healthcare Vendor Neutral Archive (VNA) and PACS Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 GE Healthcare Recent Developments and Future Plans
2.5 IBM Corporation
2.5.1 IBM Corporation Details
2.5.2 IBM Corporation Major Business
2.5.3 IBM Corporation Vendor Neutral Archive (VNA) and PACS Product and Solutions
2.5.4 IBM Corporation Vendor Neutral Archive (VNA) and PACS Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 IBM Corporation Recent Developments and Future Plans
2.6 Koninklijke Philips NV
2.6.1 Koninklijke Philips NV Details
2.6.2 Koninklijke Philips NV Major Business
2.6.3 Koninklijke Philips NV Vendor Neutral Archive (VNA) and PACS Product and Solutions
2.6.4 Koninklijke Philips NV Vendor Neutral Archive (VNA) and PACS Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Koninklijke Philips NV Recent Developments and Future Plans
2.7 Lexmark International
2.7.1 Lexmark International Details
2.7.2 Lexmark International Major Business
2.7.3 Lexmark International Vendor Neutral Archive (VNA) and PACS Product and Solutions
2.7.4 Lexmark International Vendor Neutral Archive (VNA) and PACS Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Lexmark International Recent Developments and Future Plans
2.8 McKesson Corporation
2.8.1 McKesson Corporation Details
2.8.2 McKesson Corporation Major Business
2.8.3 McKesson Corporation Vendor Neutral Archive (VNA) and PACS Product and Solutions
2.8.4 McKesson Corporation Vendor Neutral Archive (VNA) and PACS Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 McKesson Corporation Recent Developments and Future Plans
2.9 Novarad Corporation
2.9.1 Novarad Corporation Details
2.9.2 Novarad Corporation Major Business
2.9.3 Novarad Corporation Vendor Neutral Archive (VNA) and PACS Product and Solutions
2.9.4 Novarad Corporation Vendor Neutral Archive (VNA) and PACS Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 Novarad Corporation Recent Developments and Future Plans
2.10 Siemens
2.10.1 Siemens Details
2.10.2 Siemens Major Business
2.10.3 Siemens Vendor Neutral Archive (VNA) and PACS Product and Solutions
2.10.4 Siemens Vendor Neutral Archive (VNA) and PACS Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 Siemens Recent Developments and Future Plans
2.11 TeraMedica
2.11.1 TeraMedica Details
2.11.2 TeraMedica Major Business
2.11.3 TeraMedica Vendor Neutral Archive (VNA) and PACS Product and Solutions
2.11.4 TeraMedica Vendor Neutral Archive (VNA) and PACS Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11.5 TeraMedica Recent Developments and Future Plans
2.12 Merge Health
2.12.1 Merge Health Details
2.12.2 Merge Health Major Business
2.12.3 Merge Health Vendor Neutral Archive (VNA) and PACS Product and Solutions
2.12.4 Merge Health Vendor Neutral Archive (VNA) and PACS Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12.5 Merge Health Recent Developments and Future Plans
2.13 BridgeHead
2.13.1 BridgeHead Details
2.13.2 BridgeHead Major Business
2.13.3 BridgeHead Vendor Neutral Archive (VNA) and PACS Product and Solutions
2.13.4 BridgeHead Vendor Neutral Archive (VNA) and PACS Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13.5 BridgeHead Recent Developments and Future Plans
2.14 Carestream Health
2.14.1 Carestream Health Details
2.14.2 Carestream Health Major Business
2.14.3 Carestream Health Vendor Neutral Archive (VNA) and PACS Product and Solutions
2.14.4 Carestream Health Vendor Neutral Archive (VNA) and PACS Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14.5 Carestream Health Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Vendor Neutral Archive (VNA) and PACS Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Vendor Neutral Archive (VNA) and PACS Players Market Share in 2021
3.2.2 Top 10 Vendor Neutral Archive (VNA) and PACS Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Vendor Neutral Archive (VNA) and PACS Players Head Office, Products and Services Provided
3.4 Vendor Neutral Archive (VNA) and PACS Mergers & Acquisitions
3.5 Vendor Neutral Archive (VNA) and PACS New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Vendor Neutral Archive (VNA) and PACS Revenue and Market Share by Type (2017-2022)
4.2 Global Vendor Neutral Archive (VNA) and PACS Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5.1 Global Vendor Neutral Archive (VNA) and PACS Revenue Market Share by Application (2017-2022)
5.2 Global Vendor Neutral Archive (VNA) and PACS Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6.1 North America Vendor Neutral Archive (VNA) and PACS Revenue by Type (2017-2028)
6.2 North America Vendor Neutral Archive (VNA) and PACS Revenue by Application (2017-2028)
6.3 North America Vendor Neutral Archive (VNA) and PACS Market Size by Country
6.3.1 North America Vendor Neutral Archive (VNA) and PACS Revenue by Country (2017-2028)
6.3.2 United States Vendor Neutral Archive (VNA) and PACS Market Size and Forecast (2017-2028)
6.3.3 Canada Vendor Neutral Archive (VNA) and PACS Market Size and Forecast (2017-2028)
6.3.4 Mexico Vendor Neutral Archive (VNA) and PACS Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7.1 Europe Vendor Neutral Archive (VNA) and PACS Revenue by Type (2017-2028)
7.2 Europe Vendor Neutral Archive (VNA) and PACS Revenue by Application (2017-2028)
7.3 Europe Vendor Neutral Archive (VNA) and PACS Market Size by Country
7.3.1 Europe Vendor Neutral Archive (VNA) and PACS Revenue by Country (2017-2028)
7.3.2 Germany Vendor Neutral Archive (VNA) and PACS Market Size and Forecast (2017-2028)
7.3.3 France Vendor Neutral Archive (VNA) and PACS Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Vendor Neutral Archive (VNA) and PACS Market Size and Forecast (2017-2028)
7.3.5 Russia Vendor Neutral Archive (VNA) and PACS Market Size and Forecast (2017-2028)
7.3.6 Italy Vendor Neutral Archive (VNA) and PACS Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Vendor Neutral Archive (VNA) and PACS Revenue by Type (2017-2028)
8.2 Asia-Pacific Vendor Neutral Archive (VNA) and PACS Revenue by Application (2017-2028)
8.3 Asia-Pacific Vendor Neutral Archive (VNA) and PACS Market Size by Region
8.3.1 Asia-Pacific Vendor Neutral Archive (VNA) and PACS Revenue by Region (2017-2028)
8.3.2 China Vendor Neutral Archive (VNA) and PACS Market Size and Forecast (2017-2028)
8.3.3 Japan Vendor Neutral Archive (VNA) and PACS Market Size and Forecast (2017-2028)
8.3.4 South Korea Vendor Neutral Archive (VNA) and PACS Market Size and Forecast (2017-2028)
8.3.5 India Vendor Neutral Archive (VNA) and PACS Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Vendor Neutral Archive (VNA) and PACS Market Size and Forecast (2017-2028)
8.3.7 Australia Vendor Neutral Archive (VNA) and PACS Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9.1 South America Vendor Neutral Archive (VNA) and PACS Revenue by Type (2017-2028)
9.2 South America Vendor Neutral Archive (VNA) and PACS Revenue by Application (2017-2028)
9.3 South America Vendor Neutral Archive (VNA) and PACS Market Size by Country
9.3.1 South America Vendor Neutral Archive (VNA) and PACS Revenue by Country (2017-2028)
9.3.2 Brazil Vendor Neutral Archive (VNA) and PACS Market Size and Forecast (2017-2028)
9.3.3 Argentina Vendor Neutral Archive (VNA) and PACS Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Vendor Neutral Archive (VNA) and PACS Revenue by Type (2017-2028)
10.2 Middle East & Africa Vendor Neutral Archive (VNA) and PACS Revenue by Application (2017-2028)
10.3 Middle East & Africa Vendor Neutral Archive (VNA) and PACS Market Size by Country
10.3.1 Middle East & Africa Vendor Neutral Archive (VNA) and PACS Revenue by Country (2017-2028)
10.3.2 Turkey Vendor Neutral Archive (VNA) and PACS Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Vendor Neutral Archive (VNA) and PACS Market Size and Forecast (2017-2028)
10.3.4 UAE Vendor Neutral Archive (VNA) and PACS Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of Tables
Table 1. Global Vendor Neutral Archive (VNA) and PACS Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Vendor Neutral Archive (VNA) and PACS Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Vendor Neutral Archive (VNA) and PACS Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Vendor Neutral Archive (VNA) and PACS Revenue (USD Million) by Region (2017-2022)
Table 5. Global Vendor Neutral Archive (VNA) and PACS Revenue Market Share by Region (2023-2028)
Table 6. Agfa Healthcare NV Corporate Information, Head Office, and Major Competitors
Table 7. Agfa Healthcare NV Major Business
Table 8. Agfa Healthcare NV Vendor Neutral Archive (VNA) and PACS Product and Solutions
Table 9. Agfa Healthcare NV Vendor Neutral Archive (VNA) and PACS Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Dell Technologies Corporate Information, Head Office, and Major Competitors
Table 11. Dell Technologies Major Business
Table 12. Dell Technologies Vendor Neutral Archive (VNA) and PACS Product and Solutions
Table 13. Dell Technologies Vendor Neutral Archive (VNA) and PACS Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Fujifilm Holdings Corporation Corporate Information, Head Office, and Major Competitors
Table 15. Fujifilm Holdings Corporation Major Business
Table 16. Fujifilm Holdings Corporation Vendor Neutral Archive (VNA) and PACS Product and Solutions
Table 17. Fujifilm Holdings Corporation Vendor Neutral Archive (VNA) and PACS Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. GE Healthcare Corporate Information, Head Office, and Major Competitors
Table 19. GE Healthcare Major Business
Table 20. GE Healthcare Vendor Neutral Archive (VNA) and PACS Product and Solutions
Table 21. GE Healthcare Vendor Neutral Archive (VNA) and PACS Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. IBM Corporation Corporate Information, Head Office, and Major Competitors
Table 23. IBM Corporation Major Business
Table 24. IBM Corporation Vendor Neutral Archive (VNA) and PACS Product and Solutions
Table 25. IBM Corporation Vendor Neutral Archive (VNA) and PACS Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Koninklijke Philips NV Corporate Information, Head Office, and Major Competitors
Table 27. Koninklijke Philips NV Major Business
Table 28. Koninklijke Philips NV Vendor Neutral Archive (VNA) and PACS Product and Solutions
Table 29. Koninklijke Philips NV Vendor Neutral Archive (VNA) and PACS Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Lexmark International Corporate Information, Head Office, and Major Competitors
Table 31. Lexmark International Major Business
Table 32. Lexmark International Vendor Neutral Archive (VNA) and PACS Product and Solutions
Table 33. Lexmark International Vendor Neutral Archive (VNA) and PACS Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. McKesson Corporation Corporate Information, Head Office, and Major Competitors
Table 35. McKesson Corporation Major Business
Table 36. McKesson Corporation Vendor Neutral Archive (VNA) and PACS Product and Solutions
Table 37. McKesson Corporation Vendor Neutral Archive (VNA) and PACS Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Novarad Corporation Corporate Information, Head Office, and Major Competitors
Table 39. Novarad Corporation Major Business
Table 40. Novarad Corporation Vendor Neutral Archive (VNA) and PACS Product and Solutions
Table 41. Novarad Corporation Vendor Neutral Archive (VNA) and PACS Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. Siemens Corporate Information, Head Office, and Major Competitors
Table 43. Siemens Major Business
Table 44. Siemens Vendor Neutral Archive (VNA) and PACS Product and Solutions
Table 45. Siemens Vendor Neutral Archive (VNA) and PACS Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. TeraMedica Corporate Information, Head Office, and Major Competitors
Table 47. TeraMedica Major Business
Table 48. TeraMedica Vendor Neutral Archive (VNA) and PACS Product and Solutions
Table 49. TeraMedica Vendor Neutral Archive (VNA) and PACS Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 50. Merge Health Corporate Information, Head Office, and Major Competitors
Table 51. Merge Health Major Business
Table 52. Merge Health Vendor Neutral Archive (VNA) and PACS Product and Solutions
Table 53. Merge Health Vendor Neutral Archive (VNA) and PACS Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 54. BridgeHead Corporate Information, Head Office, and Major Competitors
Table 55. BridgeHead Major Business
Table 56. BridgeHead Vendor Neutral Archive (VNA) and PACS Product and Solutions
Table 57. BridgeHead Vendor Neutral Archive (VNA) and PACS Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 58. Carestream Health Corporate Information, Head Office, and Major Competitors
Table 59. Carestream Health Major Business
Table 60. Carestream Health Vendor Neutral Archive (VNA) and PACS Product and Solutions
Table 61. Carestream Health Vendor Neutral Archive (VNA) and PACS Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 62. Global Vendor Neutral Archive (VNA) and PACS Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 63. Global Vendor Neutral Archive (VNA) and PACS Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 64. Breakdown of Vendor Neutral Archive (VNA) and PACS by Company Type (Tier 1, Tier 2 and Tier 3)
Table 65. Vendor Neutral Archive (VNA) and PACS Players Head Office, Products and Services Provided
Table 66. Vendor Neutral Archive (VNA) and PACS Mergers & Acquisitions in the Past Five Years
Table 67. Vendor Neutral Archive (VNA) and PACS New Entrants and Expansion Plans
Table 68. Global Vendor Neutral Archive (VNA) and PACS Revenue (USD Million) by Type (2017-2022)
Table 69. Global Vendor Neutral Archive (VNA) and PACS Revenue Share by Type (2017-2022)
Table 70. Global Vendor Neutral Archive (VNA) and PACS Revenue Forecast by Type (2023-2028)
Table 71. Global Vendor Neutral Archive (VNA) and PACS Revenue by Application (2017-2022)
Table 72. Global Vendor Neutral Archive (VNA) and PACS Revenue Forecast by Application (2023-2028)
Table 73. North America Vendor Neutral Archive (VNA) and PACS Revenue by Type (2017-2022) & (USD Million)
Table 74. North America Vendor Neutral Archive (VNA) and PACS Revenue by Type (2023-2028) & (USD Million)
Table 75. North America Vendor Neutral Archive (VNA) and PACS Revenue by Application (2017-2022) & (USD Million)
Table 76. North America Vendor Neutral Archive (VNA) and PACS Revenue by Application (2023-2028) & (USD Million)
Table 77. North America Vendor Neutral Archive (VNA) and PACS Revenue by Country (2017-2022) & (USD Million)
Table 78. North America Vendor Neutral Archive (VNA) and PACS Revenue by Country (2023-2028) & (USD Million)
Table 79. Europe Vendor Neutral Archive (VNA) and PACS Revenue by Type (2017-2022) & (USD Million)
Table 80. Europe Vendor Neutral Archive (VNA) and PACS Revenue by Type (2023-2028) & (USD Million)
Table 81. Europe Vendor Neutral Archive (VNA) and PACS Revenue by Application (2017-2022) & (USD Million)
Table 82. Europe Vendor Neutral Archive (VNA) and PACS Revenue by Application (2023-2028) & (USD Million)
Table 83. Europe Vendor Neutral Archive (VNA) and PACS Revenue by Country (2017-2022) & (USD Million)
Table 84. Europe Vendor Neutral Archive (VNA) and PACS Revenue by Country (2023-2028) & (USD Million)
Table 85. Asia-Pacific Vendor Neutral Archive (VNA) and PACS Revenue by Type (2017-2022) & (USD Million)
Table 86. Asia-Pacific Vendor Neutral Archive (VNA) and PACS Revenue by Type (2023-2028) & (USD Million)
Table 87. Asia-Pacific Vendor Neutral Archive (VNA) and PACS Revenue by Application (2017-2022) & (USD Million)
Table 88. Asia-Pacific Vendor Neutral Archive (VNA) and PACS Revenue by Application (2023-2028) & (USD Million)
Table 89. Asia-Pacific Vendor Neutral Archive (VNA) and PACS Revenue by Region (2017-2022) & (USD Million)
Table 90. Asia-Pacific Vendor Neutral Archive (VNA) and PACS Revenue by Region (2023-2028) & (USD Million)
Table 91. South America Vendor Neutral Archive (VNA) and PACS Revenue by Type (2017-2022) & (USD Million)
Table 92. South America Vendor Neutral Archive (VNA) and PACS Revenue by Type (2023-2028) & (USD Million)
Table 93. South America Vendor Neutral Archive (VNA) and PACS Revenue by Application (2017-2022) & (USD Million)
Table 94. South America Vendor Neutral Archive (VNA) and PACS Revenue by Application (2023-2028) & (USD Million)
Table 95. South America Vendor Neutral Archive (VNA) and PACS Revenue by Country (2017-2022) & (USD Million)
Table 96. South America Vendor Neutral Archive (VNA) and PACS Revenue by Country (2023-2028) & (USD Million)
Table 97. Middle East & Africa Vendor Neutral Archive (VNA) and PACS Revenue by Type (2017-2022) & (USD Million)
Table 98. Middle East & Africa Vendor Neutral Archive (VNA) and PACS Revenue by Type (2023-2028) & (USD Million)
Table 99. Middle East & Africa Vendor Neutral Archive (VNA) and PACS Revenue by Application (2017-2022) & (USD Million)
Table 100. Middle East & Africa Vendor Neutral Archive (VNA) and PACS Revenue by Application (2023-2028) & (USD Million)
Table 101. Middle East & Africa Vendor Neutral Archive (VNA) and PACS Revenue by Country (2017-2022) & (USD Million)
Table 102. Middle East & Africa Vendor Neutral Archive (VNA) and PACS Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Vendor Neutral Archive (VNA) and PACS Picture
Figure 2. Global Vendor Neutral Archive (VNA) and PACS Revenue Market Share by Type in 2021
Figure 3. Cloud-hosted
Figure 4. On-Site (Premise)
Figure 5. Hybrid
Figure 6. Vendor Neutral Archive (VNA) and PACS Revenue Market Share by Application in 2021
Figure 7. Enterprise Picture
Figure 8. Cardiology Picture
Figure 9. Radiology Picture
Figure 10. Global Vendor Neutral Archive (VNA) and PACS Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 11. Global Vendor Neutral Archive (VNA) and PACS Revenue and Forecast (2017-2028) & (USD Million)
Figure 12. Global Vendor Neutral Archive (VNA) and PACS Revenue Market Share by Region (2017-2028)
Figure 13. Global Vendor Neutral Archive (VNA) and PACS Revenue Market Share by Region in 2021
Figure 14. North America Vendor Neutral Archive (VNA) and PACS Revenue (USD Million) and Growth Rate (2017-2028)
Figure 15. Europe Vendor Neutral Archive (VNA) and PACS Revenue (USD Million) and Growth Rate (2017-2028)
Figure 16. Asia-Pacific Vendor Neutral Archive (VNA) and PACS Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. South America Vendor Neutral Archive (VNA) and PACS Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. Middle East and Africa Vendor Neutral Archive (VNA) and PACS Revenue (USD Million) and Growth Rate (2017-2028)
Figure 19. Vendor Neutral Archive (VNA) and PACS Market Drivers
Figure 20. Vendor Neutral Archive (VNA) and PACS Market Restraints
Figure 21. Vendor Neutral Archive (VNA) and PACS Market Trends
Figure 22. Agfa Healthcare NV Recent Developments and Future Plans
Figure 23. Dell Technologies Recent Developments and Future Plans
Figure 24. Fujifilm Holdings Corporation Recent Developments and Future Plans
Figure 25. GE Healthcare Recent Developments and Future Plans
Figure 26. IBM Corporation Recent Developments and Future Plans
Figure 27. Koninklijke Philips NV Recent Developments and Future Plans
Figure 28. Lexmark International Recent Developments and Future Plans
Figure 29. McKesson Corporation Recent Developments and Future Plans
Figure 30. Novarad Corporation Recent Developments and Future Plans
Figure 31. Siemens Recent Developments and Future Plans
Figure 32. TeraMedica Recent Developments and Future Plans
Figure 33. Merge Health Recent Developments and Future Plans
Figure 34. BridgeHead Recent Developments and Future Plans
Figure 35. Carestream Health Recent Developments and Future Plans
Figure 36. Global Vendor Neutral Archive (VNA) and PACS Revenue Share by Players in 2021
Figure 37. Vendor Neutral Archive (VNA) and PACS Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 38. Global Top 3 Players Vendor Neutral Archive (VNA) and PACS Revenue Market Share in 2021
Figure 39. Global Top 10 Players Vendor Neutral Archive (VNA) and PACS Revenue Market Share in 2021
Figure 40. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 41. Global Vendor Neutral Archive (VNA) and PACS Revenue Share by Type in 2021
Figure 42. Global Vendor Neutral Archive (VNA) and PACS Market Share Forecast by Type (2023-2028)
Figure 43. Global Vendor Neutral Archive (VNA) and PACS Revenue Share by Application in 2021
Figure 44. Global Vendor Neutral Archive (VNA) and PACS Market Share Forecast by Application (2023-2028)
Figure 45. North America Vendor Neutral Archive (VNA) and PACS Sales Market Share by Type (2017-2028)
Figure 46. North America Vendor Neutral Archive (VNA) and PACS Sales Market Share by Application (2017-2028)
Figure 47. North America Vendor Neutral Archive (VNA) and PACS Revenue Market Share by Country (2017-2028)
Figure 48. United States Vendor Neutral Archive (VNA) and PACS Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Canada Vendor Neutral Archive (VNA) and PACS Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Mexico Vendor Neutral Archive (VNA) and PACS Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Europe Vendor Neutral Archive (VNA) and PACS Sales Market Share by Type (2017-2028)
Figure 52. Europe Vendor Neutral Archive (VNA) and PACS Sales Market Share by Application (2017-2028)
Figure 53. Europe Vendor Neutral Archive (VNA) and PACS Revenue Market Share by Country (2017-2028)
Figure 54. Germany Vendor Neutral Archive (VNA) and PACS Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. France Vendor Neutral Archive (VNA) and PACS Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. United Kingdom Vendor Neutral Archive (VNA) and PACS Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Russia Vendor Neutral Archive (VNA) and PACS Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Italy Vendor Neutral Archive (VNA) and PACS Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Asia-Pacific Vendor Neutral Archive (VNA) and PACS Sales Market Share by Type (2017-2028)
Figure 60. Asia-Pacific Vendor Neutral Archive (VNA) and PACS Sales Market Share by Application (2017-2028)
Figure 61. Asia-Pacific Vendor Neutral Archive (VNA) and PACS Revenue Market Share by Region (2017-2028)
Figure 62. China Vendor Neutral Archive (VNA) and PACS Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Japan Vendor Neutral Archive (VNA) and PACS Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. South Korea Vendor Neutral Archive (VNA) and PACS Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. India Vendor Neutral Archive (VNA) and PACS Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Southeast Asia Vendor Neutral Archive (VNA) and PACS Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Australia Vendor Neutral Archive (VNA) and PACS Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. South America Vendor Neutral Archive (VNA) and PACS Sales Market Share by Type (2017-2028)
Figure 69. South America Vendor Neutral Archive (VNA) and PACS Sales Market Share by Application (2017-2028)
Figure 70. South America Vendor Neutral Archive (VNA) and PACS Revenue Market Share by Country (2017-2028)
Figure 71. Brazil Vendor Neutral Archive (VNA) and PACS Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Argentina Vendor Neutral Archive (VNA) and PACS Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Middle East and Africa Vendor Neutral Archive (VNA) and PACS Sales Market Share by Type (2017-2028)
Figure 74. Middle East and Africa Vendor Neutral Archive (VNA) and PACS Sales Market Share by Application (2017-2028)
Figure 75. Middle East and Africa Vendor Neutral Archive (VNA) and PACS Revenue Market Share by Country (2017-2028)
Figure 76. Turkey Vendor Neutral Archive (VNA) and PACS Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Saudi Arabia Vendor Neutral Archive (VNA) and PACS Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. UAE Vendor Neutral Archive (VNA) and PACS Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. Methodology
Figure 80. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
